What question did this study set out to answer?

To update the 2002 U.S. Preventive Services Task Force recommendations regarding the efficacy and harms of aspirin in the primary prevention of cardiovascular disease.

March 17, 2009Annals of Internal Medicine

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

View Full Paper

Ask AI

Bookmark

Why the study?

Does aspirin prevent cardiovascular disease (myocardial infarction and stroke) in men and women without prior cardiovascular disease?

Population

Men age 45 to 79 years and women age 55 to 79 years for the primary prevention of cardiovascular disease

Design

Guideline

Discussion

Member takes

Implication

Supports targeted aspirin use for primary CVD prevention in middle-aged adults when benefits exceed GI risks; updates 2002 USPSTF guidance with stratified evidence.

Key Points

To update the 2002 U.S. Preventive Services Task Force recommendations regarding the efficacy and harms of aspirin in the primary prevention of cardiovascular disease.
Reviewed literature published since 2002 evaluating the benefits and harms of aspirin for primary prevention of cardiovascular disease, specifically myocardial infarction and stroke.
Synthesized clinical evidence stratified by sex and age categories.
Aspirin is recommended for men aged 45 to 79 years when myocardial infarction reduction outweighs gastrointestinal hemorrhage risk, and for women aged 55 to 79 years when ischemic stroke reduction outweighs gastrointestinal hemorrhage risk.
Aspirin use is discouraged for cardiovascular disease prevention in men younger than 45 years and women younger than 55 years, while evidence remains insufficient to evaluate the net benefit in adults aged 80 years or older.

Structured PICO

Does aspirin prevent cardiovascular disease (myocardial infarction and stroke) in men and women without prior cardiovascular disease?

Population

Men age 45 to 79 years and women age 55 to 79 years for the primary prevention of cardiovascular disease

Intervention

Aspirin

Outcome

Cardiovascular disease, including myocardial infarction and strokehard clinical

The USPSTF recommends sex- and age-specific use of aspirin for the primary prevention of cardiovascular disease when the benefits outweigh the risks of gastrointestinal bleeding.

Cite This Study

A 2009 study studied this question.

synapsesocial.com/papers/6a7d48cc97c2c6e465965b48 https://doi.org/10.7326/0003-4819-150-6-200903170-00008

Topics

Dual antiplatelet therapy Cardiovascular prevention Women and heart disease

View Full Paper

Ask AI

Bookmark

Implication

Supports targeted aspirin use for primary CVD prevention in middle-aged adults when benefits exceed GI risks; updates 2002 USPSTF guidance with stratified evidence.

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider